International Research journal of Management Science and Technology

  ISSN 2250 - 1959 (online) ISSN 2348 - 9367 (Print) New DOI : 10.32804/IRJMST

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 362    Submit Your Rating     Cite This   Download        Certificate

SYNTHESIS AND PHARMACOLOGICAL EVALUTION OF PYRAZOLO BENZOHIAZOLES AND THIAZOLIDINE DERIVATIVATES

    2 Author(s):  S.K.SHARMA . R,S.V.MURALIMOHAN RAO

Vol -  4, Issue- 1 ,         Page(s) : 312 - 334  (2013 ) DOI : https://doi.org/10.32804/IRJMST

Abstract

Synthesis and pharmacological evaluation and characterization of thiazolidine derivatives asanti hyperglycemic agents. The chemistry of these systems involves considerable biological interest as Thiazolidin-4-one nucleus has many pharmacological properties.that thiazolidin-4-ones derivativesexhibited potent anti-HIV, analgesic, anti-tubercular, anti-histaminic, anti-viral, hypoglycemic, anti-hyperlipidemic, anti-Inflammatory and CNS activities.

  1. Eicher, T.; Hauptmann, S. (2nd ed. 2003). The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications. Wiley-VCH.
  2. Tan et al., 2006.
  3. Review article (properties, biological activities, syntheses of pyrazoles): A. Schmidt, A.Dreger (2011). "Recent Advances in the Chemistry of Pyrazoles. Properties, ".
  4. Fowden; Noe, Ridd and White, (1959). Proc. Chem. SOC. 131.
  5. T. E. Gilchrist "Heterocyclic Chemistry" 3rd Edition, Longman, 1992.
  6. International Journal of Natural Product Science 2012; Spl Issue 1: 247.
  7. Tweit, R. C., J. Chem. Soc., 1970, 687.
  8. Rawal, R. K., Srivastava, T., Haq, W., Katti, S. B., J. Chem.  Res., 368 (2004).
  9. Yadav, R., Srivastava, S. D., Srivastava, S.K., Ind.J. Chem44B: 1262-1266 (2005).
  10. Kidwai, M., Negi, N., Misra, P., J. Ind. Chem. Soc., 77:     46-47  (2000).
  11. Kidwai, M., Negi, N., Misra, P., J. Ind. Chem. Soc., 77:     46-47  (2000).Srivastava, V. K., Palit,
  12. G., et al, J. Indian Chem. Soc., 67:     335-   338 (1990).
  13. Amato.A.A.,Neves.F.A., 2012. Idealized PPARgamma-Based Therapies: Lessons from Bench and Bedside. PPAR Res., (2012).
  14. Shinkai.H, et al., Isoxazolidine-3,5-dione and Noncyclic 1,3-Dicarbonyl Compounds as 
  15. Hypoglycemic Agents, J. Med. Chem. (1998), 41, 1927-1933.
  16. Sriram, D., Yogeeswari, P., Ashok kumar T. G., J. Indian Pharm. Sci., 67(4): 496-499, (2005).
  17. Omaima Mohamed AbdElhafez et al., Arch. Pharm. Res.,      26(8):686-696 (2003).

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details